Oklahoma 2022 Regular Session

Oklahoma Senate Bill SB164 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1	1
2	2
	3	+	SB164 HFLR Page 1
	4	+	BOLD FACE denotes Committee Amendments. 1
	5	+	2
	6	+	3
	7	+	4
	8	+	5
	9	+	6
	10	+	7
	11	+	8
	12	+	9
	13	+	10
	14	+	11
	15	+	12
	16	+	13
	17	+	14
	18	+	15
	19	+	16
	20	+	17
	21	+	18
	22	+	19
	23	+	20
	24	+	21
	25	+	22
	26	+	23
	27	+	24
3	28
4		-	An Act
5		-	ENROLLED SENATE
	29	+	HOUSE OF REPRESENTATIVES - FLOOR VERSION
	30	+
	31	+	STATE OF OKLAHOMA
	32	+
	33	+	1st Session of the 58th Legislature (2021)
	34	+
	35	+	ENGROSSED SENATE
6	36		BILL NO. 164 By: Stanley of the Senate
7	37
8	38		and
9	39
10		-	Roe and Pittman of the
11		-	House
	40	+	Roe of the House
12	41
13	42
14	43
15	44
16	45		An Act relating to medical care; amending 63 O.S.
17	46		2011, Section 3102A, which relates to experimental
18	47		treatments, tests or drugs; authorizing parent or
19	48		legal guardian to provide informed consent for
20	49		incapacitated minor; modifying certain condition;
21	50		providing for participation in a research program or
22	51		experimental procedures without informed consent
23	52		under certain conditions; specifying applicability of
24	53		certain provisions; providing certain construction;
25	54		and providing an effective date .
26	55
27	56
28	57
29	58
30		-	SUBJECT: Experimental treatments, tests or drugs
31		-
32	59		BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
33		-
34	60		SECTION 1. AMENDATORY 63 O.S. 2011, Section 3102A, is
35	61		amended to read as follows:
36		-
37	62		Section 3102A. A. When an adult person a patient, because of a
38	63		medical condition, is treated by a licensed medical doctor or doctor
39	64		of osteopathy holding a faculty appointmen t at a medical school
40	65		accredited by the Liaison Committee on Medical Education or American
41	66		Osteopathic Association, or holding clinical privileges at a
42	67		healthcare institution that conducts human subject research approved
	68	+
	69	+	SB164 HFLR Page 2
	70	+	BOLD FACE denotes Committee Amendments. 1
	71	+	2
	72	+	3
	73	+	4
	74	+	5
	75	+	6
	76	+	7
	77	+	8
	78	+	9
	79	+	10
	80	+	11
	81	+	12
	82	+	13
	83	+	14
	84	+	15
	85	+	16
	86	+	17
	87	+	18
	88	+	19
	89	+	20
	90	+	21
	91	+	22
	92	+	23
	93	+	24
	94	+
43	95		by local an accredited institutional review board, and such person
44	96		patient is incapable of giving informed consent for a local-
45	97		institutional-review-board-approved an accredited-institutional-
46	98		review-board-approved experimental treatment, test or drug, then the
47		-
48		-	ENR. S. B. NO. 164 Page 2
49	99		administration of such treatment, test or drug may proceed upon
50	100		obtaining informed consent of a parent, legal guardian, attorney -in-
51	101		fact with health care decision authority, or a family member in the
52	102		following order of priority:
53		-
54	103		1. The If the patient is a minor, the parent or legal gua rdian;
55	104		and
56		-
57	105		2. If the patient is an adult:
58		-
59	106		a. the spouse, unless the patient has no spouse, or is
60	107		separated, or the spouse is physically or mentally
61	108		incapable of giving consent, or the spouse ’s location
62	109		is unknown or the spouse is overseas, or the spouse i s
63	110		otherwise not available ;,
	111	+	2. An
	112	+	b. an adult son or daughter ;,
	113	+	3. Either
	114	+	c. either parent;,
	115	+	4. An
	116	+	d. an adult brother or sister ;, or
	117	+	5. A
	118	+	e. a relative by blood or marriage.
64	119
65		-	2. An
66		-
67		-	b. an adult son or daughter;,
68		-
69		-	3. Either
70		-
71		-	c. either parent;,
72		-
73		-	4. An
74		-
75		-	d. an adult brother or sister;, or
76		-
77		-	5. A
78		-
79		-	e. a relative by blood or marria ge.
	120	+	SB164 HFLR Page 3
	121	+	BOLD FACE denotes Committee Amendments. 1
	122	+	2
	123	+	3
	124	+	4
	125	+	5
	126	+	6
	127	+	7
	128	+	8
	129	+	9
	130	+	10
	131	+	11
	132	+	12
	133	+	13
	134	+	14
	135	+	15
	136	+	16
	137	+	17
	138	+	18
	139	+	19
	140	+	20
	141	+	21
	142	+	22
	143	+	23
	144	+	24
80	145
81	146		B. Nothing If the patient is an adult, nothing in this section
82	147		shall authorize such legal guardian, attorney -in-fact or family
83	148		member to consent to treatment in contravention to such
84	149		incapacitated person’s patient’s expressed permission or prohibition
85	150		regarding such treatment.
86		-
87	151		C. In a life-threatening emergency, consent of such a n
88	152		incapacitated person to any research program or experimental
89	153		procedure shall not be required when the accredited institutional
90	154		review board responsible for the review, approval and continuing
91		-
92		-	ENR. S. B. NO. 164 Page 3
93	155		review of the research activity has approved both the research
94	156		activity and a waiver of informed consent and has both found and
95	157		documented that the requirements for an exception from informed
96	158		consent requirements for emergency research, as provided under Part
97	159		50 of Title 21 or Part 46 of Title 45 of the Code of Feder al
98	160		Regulations, as amended, have been satisfied. This subsection shall
99	161		apply to all pre-hospital or hospital research conducted by a
100	162		licensed medical doctor or doctor of osteopathy.
101		-
102	163		D. Nothing in this section shall permit a parent, legal
103	164		guardian, attorney-in-fact or family member to authorize the use of
104	165		an experimental treatment, test or drug on a pregnant patient.
105		-
106	166		SECTION 2. This act shall become effective November 1, 2021.
107	167
108		-
109		-	ENR. S. B. NO. 164 Page 4
110		-	Passed the Senate the 2nd day of March, 2021.
111		-
112		-
113		-
114		-	Presiding Officer of the Senate
115		-
116		-
117		-	Passed the House of Representatives the 21st day of April, 2021.
118		-
119		-
120		-
121		-	Presiding Officer of the House
122		-	of Representatives
123		-
124		-	OFFICE OF THE GOVERNOR
125		-	Received by the Office of the Governor this _______ _____________
126		-	day of _________________ __, 20_______, at _______ o'clock _______ M.
127		-	By: _______________________________ __
128		-	Approved by the Governor of the State of Oklahoma this _____ ____
129		-	day of _________________ __, 20_______, at _______ o'clock _______ M.
130		-
131		-	_________________________________
132		-	Governor of the State of Oklahoma
133		-
134		-
135		-	OFFICE OF THE SECRETARY OF STATE
136		-	Received by the Office of the Secretary of State this _______ ___
137		-	day of __________________, 20 _______, at _______ o'clock _______ M.
138		-	By: _______________________________ __
	168	+	COMMITTEE REPORT BY: COMMITTEE ON PUBLIC HEALTH, dated 03/31/2 021 -
	169	+	DO PASS.